Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study-Reference-Cited by-同舟云学术

Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study

Published:2022-11 Issue:5 Volume:85 Page:e140-e144
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Wan Eric Yuk Fai^ORCID,Mok Anna Hoi Ying,Yan Vincent Ka Chun^ORCID,Wang Boyuan,Zhang Ran^ORCID,Hong Sabrina Nan,Chui Celine Sze Ling,Li Xue,Wong Carlos King Ho^ORCID,Lai Francisco Tsz Tsun^ORCID,Tan Kathryn Choon Beng^ORCID,Lau Chak Sing,Wong Ian Chi Kei^ORCID,Chan Esther Wai Yin

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference10 articles.

1. Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study;Yin;J Infect,2022

2. Mesfin Y., Chen D., Bond H., Lam V., Cheung J., Wong J., et al. Epidemiology of infections with SARS-CoV-2 Omicron BA. 2 variant in Hong Kong, January-March 2022. medRxiv. 2022.

3. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study;Wan;Lancet Infect Dis,2021

4. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study;Wan;Lancet Reg Health – Western Pacific,2022

5. Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series;Wan;Lancet Healthy Longevity,2022

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for long-term cardiovascular post-acute sequelae of COVID-19 infection: A nested case-control study in Hong Kong;npj Cardiovascular Health;2024-08-02

2. The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China;Frontiers in Immunology;2024-05-31

3. Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents;Frontiers in Immunology;2024-05-15

4. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment;Diabetologia;2024-02-20

5. Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up;Vaccines;2024-01-29